UBS Group
FPRX

UBS Group’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-56,930
Closed -$2.14M 9101
2021
Q1
$2.14M Buy
56,930
+50,932
+849% +$1.92M ﹤0.01% 2706
2020
Q4
$102K Buy
5,998
+1,768
+42% +$30.1K ﹤0.01% 4694
2020
Q3
$19K Sell
4,230
-54,317
-93% -$244K ﹤0.01% 5502
2020
Q2
$357K Buy
58,547
+37,531
+179% +$229K ﹤0.01% 3620
2020
Q1
$48K Sell
21,016
-29,990
-59% -$68.5K ﹤0.01% 4986
2019
Q4
$234K Sell
51,006
-68,207
-57% -$313K ﹤0.01% 4505
2019
Q3
$462K Buy
119,213
+117,135
+5,637% +$454K ﹤0.01% 3789
2019
Q2
$12K Sell
2,078
-776
-27% -$4.48K ﹤0.01% 6102
2019
Q1
$39K Sell
2,854
-96,584
-97% -$1.32M ﹤0.01% 4921
2018
Q4
$925K Buy
99,438
+90,954
+1,072% +$846K ﹤0.01% 3048
2018
Q3
$118K Buy
8,484
+1,927
+29% +$26.8K ﹤0.01% 4596
2018
Q2
$104K Sell
6,557
-92,096
-93% -$1.46M ﹤0.01% 4538
2018
Q1
$1.7M Buy
98,653
+87,363
+774% +$1.5M ﹤0.01% 2662
2017
Q4
$248K Buy
11,290
+4,126
+58% +$90.6K ﹤0.01% 3882
2017
Q3
$293K Sell
7,164
-512
-7% -$20.9K ﹤0.01% 3776
2017
Q2
$231K Buy
7,676
+1,604
+26% +$48.3K ﹤0.01% 3823
2017
Q1
$220K Sell
6,072
-15,986
-72% -$579K ﹤0.01% 3774
2016
Q4
$1.11M Buy
22,058
+7,170
+48% +$359K ﹤0.01% 2740
2016
Q3
$782K Buy
14,888
+13,086
+726% +$687K ﹤0.01% 2880
2016
Q2
$75K Buy
1,802
+987
+121% +$41.1K ﹤0.01% 4391
2016
Q1
$33K Sell
815
-61
-7% -$2.47K ﹤0.01% 5012
2015
Q4
$37K Buy
+876
New +$37K ﹤0.01% 5019
2015
Q3
Sell
-898
Closed -$22K 7023
2015
Q2
$22K Buy
+898
New +$22K ﹤0.01% 5432